Interesting to see what market thinks of this Ann today.
Momentum building in share price leading up to this Ann and no increase yesterday.
Clearly not marked as price sensitive but the wording suggesting confidence, can't see them "looking forward" or it being "ground breaking" if unsuccessful results being announced in Dec.
This Ann yesterday should bolster confidence in Neu's position and increase buying Neu currently undervalued on Daybue alone, leading into what seems inevitable positive results in PMS in Dec.
We should be humming to $20 now and on Ann day of success $25 -$30 absolute base case, I think we 100% agree on this type of valuation now.
Ann: Neuren completes Phelan-McDermid syndrome Phase 2 trial, page-27
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |